Home Cart Sign in  
Chemical Structure| 16290-26-9 Chemical Structure| 16290-26-9

Structure of 3,4-Dihydroxybenzylamine HBr
CAS No.: 16290-26-9

Chemical Structure| 16290-26-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

3,4-Dihydroxybenzylamine hydrobromide (NSC 263475 hydrobromide) is an improved dopamine analog cytotoxic and inhibits DNA polymerase activity in melanoma cells. 3,4-Dihydroxybenzylamine hydrobromide (NSC 263475 hydrobromide) displays growth inhibitory activity in melanoma cell lines with varying degrees of tyrosinase activity.

Synonyms: 3,4-Dihydroxybenzylamine hydrobromide; NSC 263475 hydrobromide

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 3,4-Dihydroxybenzylamine HBr

CAS No. :16290-26-9
Formula : C7H10BrNO2
M.W : 220.06
SMILES Code : OC1=CC=C(CN)C=C1O.[H]Br
Synonyms :
3,4-Dihydroxybenzylamine hydrobromide; NSC 263475 hydrobromide
MDL No. :MFCD00012859
InChI Key :BVFZTXFCZAXSHN-UHFFFAOYSA-N
Pubchem ID :13343562

Safety of 3,4-Dihydroxybenzylamine HBr

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Related Pathways of 3,4-Dihydroxybenzylamine HBr

DNA

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.54mL

0.91mL

0.45mL

22.72mL

4.54mL

2.27mL

45.44mL

9.09mL

4.54mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories